Literature DB >> 34814231

Enzyme Control Over Ferric Iron Magnetostructural Properties.

Huan Wang1,2, Michael B Cleary1,2, Luke C Lewis3, Jeffrey W Bacon4, Peter Caravan1,2, Hannah S Shafaat3, Eric M Gale1,2.   

Abstract

Fe3+ complexes in aqueous solution can exist as discrete mononuclear species or multinuclear magnetically coupled species. Stimuli-driven change to Fe3+ speciation represents a powerful mechanistic basis for magnetic resonance sensor technology, but ligand design strategies to exert precision control of aqueous Fe3+ magnetostructural properties are entirely underexplored. In pursuit of this objective, we rationally designed a ligand to strongly favor a dinuclear μ-oxo-bridged and antiferromagnetically coupled complex, but which undergoes carboxylesterase mediated transformation to a mononuclear high-spin Fe3+ chelate resulting in substantial T1 -relaxivity increase. The data communicated demonstrate proof of concept for a novel and effective strategy to exert biochemical control over aqueous Fe3+ magnetic, structural, and relaxometric properties.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  Bioresponsive; Imaging; Iron; Magnetic resonance; Sensors

Mesh:

Substances:

Year:  2021        PMID: 34814231      PMCID: PMC8935392          DOI: 10.1002/anie.202114019

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  27 in total

1.  Switchable Polymerization Catalysts.

Authors:  Aaron J Teator; Dominika N Lastovickova; Christopher W Bielawski
Journal:  Chem Rev       Date:  2015-11-20       Impact factor: 60.622

2.  A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach.

Authors:  Joseph A Duimstra; Frank J Femia; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2005-09-21       Impact factor: 15.419

Review 3.  Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Abhishek Gupta; Peter Caravan; William S Price; Carlos Platas-Iglesias; Eric M Gale
Journal:  Inorg Chem       Date:  2020-05-05       Impact factor: 5.165

4.  Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex.

Authors:  Huan Wang; Veronica Clavijo Jordan; Ian A Ramsay; Mozhdeh Sojoodi; Bryan C Fuchs; Kenneth K Tanabe; Peter Caravan; Eric M Gale
Journal:  J Am Chem Soc       Date:  2019-03-28       Impact factor: 15.419

5.  Classification of Metal-based Drugs According to Their Mechanisms of Action.

Authors:  Eszter Boros; Paul J Dyson; Gilles Gasser
Journal:  Chem       Date:  2019-11-07       Impact factor: 22.804

6.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents.

Authors:  Jody L Major; Thomas J Meade
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

7.  Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studies.

Authors:  R B Lauffer; W L Greif; D D Stark; A C Vincent; S Saini; V J Wedeen; T J Brady
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

8.  Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH.

Authors:  Ferenc K Kalman; Mark Woods; Peter Caravan; Paul Jurek; Marga Spiller; Gyula Tircsó; Róbert Kiraly; Ernö Brücher; A Dean Sherry
Journal:  Inorg Chem       Date:  2007-06-01       Impact factor: 5.165

9.  Self-Immolative Activation of β-Galactosidase-Responsive Probes for In Vivo MR Imaging in Mouse Models.

Authors:  Laura M Lilley; Sarah Kamper; Michael Caldwell; Zer Keen Chia; David Ballweg; Luke Vistain; Jeffrey Krimmel; Teresa Anne Mills; Keith MacRenaris; Paul Lee; Emily Alexandria Waters; Thomas J Meade
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-21       Impact factor: 15.336

10.  Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.

Authors:  Brian C Bales; Brian Grimmond; Bruce F Johnson; M Todd Luttrell; Dan E Meyer; Tatyana Polyanskaya; Michael J Rishel; Jeannette Roberts
Journal:  Contrast Media Mol Imaging       Date:  2019-12-20       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.